| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.05 | 0.2 |